Clinical Trial Update: Comparison of the Ganglionated Plexi Activity in Patients With Different Forms of Atrial Fibrillation Guided by SUMO Technology [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating how ganglionated plexi activity differs across forms of atrial fibrillation using SUMO technology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Atrial Fibrillation | Phase 1, Phase 2 | Status: UNKNOWN